Clinical Impact of the Polypill for Cardiovascular Prevention in Latin America: A Consensus Statement of the Inter-American Society of Cardiology

Publication date: March 2019Source: Global Heart, Volume 14, Issue 1Author(s): Álvaro Sosa-Liprandi, María Inés Sosa Liprandi, Erick Alexánderson, Álvaro Avezum, Fernando Lanas, José Patricio López-Jaramillo, Felipe Martínez, Carlos I. Ponte-Negretti N, Fernando Wyss, José Ramón González Juanatey, Pablo PerelAbstractThe burden of cardiovascular diseases (CVD) is increasing, particularly in low-middle-income countries such as most of Latin America. This region presents specific socioeconomic characteristics, generating a high incidence of CVD despite efforts to control the problem. A consensus statement has been developed by Inter-American Society of Cardiology with the aim of answering some important questions related to CVD in this region and the role of the polypill in cardiovascular (CV) prevention as an intervention to address these issues. A multidisciplinary team composed of Latin American experts in the prevention of CVD was convened by the Inter-American Society of Cardiology and participated in the process and the formulation of statements. To characterize the prevailing situation in Latin American countries, we describe the most significant CV risk factors in the region. The barriers that impair the use of CV essential medications are also reviewed. The role of therapeutic adherence in CV prevention and how the polypill emerges as an effective strategy for optimizing adherence, accessibility, and affordability in the treatment of CVDs are discussed in det...
Source: Global Heart - Category: Cardiology Source Type: research